Transversus Abdominal Plane Block at Total Laparoscopic Hysterectomy: Effect on Quality of Recovery (TAP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01479270|
Recruitment Status : Completed
First Posted : November 24, 2011
Last Update Posted : October 24, 2012
|Condition or disease||Intervention/treatment||Phase|
|Pain, Postoperative Anesthesia||Drug: TAP Block of 0.25% Ropivacaine with 1:200,000 Epinephrine||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||58 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||Randomized Trial of Transversus Abdominal Plane (TAP) Block at Total Laparoscopic Hysterectomy: Effect of Regional Analgesia on Quality of Recovery|
|Study Start Date :||May 2011|
|Actual Primary Completion Date :||September 2011|
|Actual Study Completion Date :||January 2012|
Active Comparator: TAP Block
20mL of 0.25% Ropivacaine with Epinephrine 1:200,000 is injected into bilateral transversus abdominal planes under ultrasound guidance.
Drug: TAP Block of 0.25% Ropivacaine with 1:200,000 Epinephrine
Bilateral transversus abdominal plane injection under ultrasound guidance, done at conclusion of hysterectomy procedure, prior to emergence from general anesthesia
No Intervention: No Block
Patients randomized to this arm have band aids applied to sites on lateral abdomen without injection.
- QoR-40 survey on postop day #1 [ Time Frame: 48 hours postop ]40 question survey completed on paper or by telephone on POD#1 or POD#2
- narcotic use [ Time Frame: 24 hours postop ]narcotic use in mg of Morphine will be recorded
- VAS for pain [ Time Frame: 24 hours postop ]visual analogue scales for pain will be completed on POD#0 and POD#1
- Anesthesia time [ Time Frame: intraop ]Time of surgery and total time under anesthesia in the OR will be recorded.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01479270
|Principal Investigator:||Sarah M Kane, MD||MetroHealth Medical Center|